DLX6-AS1 Activated by H3K4me1 Enhanced Secondary Cisplatin Resistance of Lung Squamous Cell Carcinoma through Modulating miR-181a-5p/miR-382-5p/CELF1 Axis

Secondary cisplatin resistance majorly undermines the cisplatin efficacy leading to a worse prognosis. In this respect, researchers identified the role of the DLX6-AS1/miR-181a-5p/miR-382-5p/CELF1 axis in regulating cisplatin resistance of lung squamous cell carcinoma.